Skip to main content
SpringerLink
Log in

Epstein-Barr Virus and Lymphomas: An Overview

  • Chapter
Book cover Etiology of Hodgkin’s Disease

Part of the book series: NATO ASI Series ((NSSA,volume 280))

Abstract

Epstein-Barr virus (EBV) is a ubiquitous human herpes virus which is found as a predominantly asymptomatic infection in all human communities. Primary EBV infection usually occurs in childhood and, once infected, individuals become life-long virus carriers. The virus is the causative agent of infectious mononucleosis (IM), a self-limiting lymphoproliferative disease resulting from delayed primary EBV infection, and is also associated with a number of malignant tumours, including Burkitt’s lymphoma (BL) and lymphomas arising in immunocompromised patients (Miller, 1990). The B lymphotropic nature of EBV is evidenced by its association with these lymphoproliferations and by the ability of the virus to immortalise normal resting B lymphocytes in vitro, converting them into permanently growing lymphoblastoid cell lines (LCLs) (Nilsson et al., 1971). When peripheral blood lymphocytes from EBV seropositive individuals are placed in culture, the few virus-infected B-cells that are present regularly give rise to spontaneous outgrowth of EBV-transformed LCLs provided that immune T-cells are either removed or inhibited by addition of cyclosporin A to the culture (Rickinson et al., 1984). This phenomenon highlights the importance of EBV-specific cytotoxic T lymphocytes (CTLs) in controlling EBV-induced B-cell transformation (Fig. 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allday MJ, Crawford DH (1988) Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet i:855

    Article  Google Scholar 

  • Anagnostopoulos I, Hummel M, Finn T, Tiemann M, Korbjuhn P, Dimmler C, Gatter K, Dallenbach F, Parwaresch M, Stein H (1992) Heterogenous Epstein-Barr virus infection patterns in peripheral T cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 80:1804

    PubMed  CAS  Google Scholar 

  • Andersson ML, Stam NJ, Klein G, Pleg HL, Masucci MG (1991) Aberrant expression of HLA Class-I antigens in Burkitt lymphoma cells. Int J Cancer 47:544

    Article  PubMed  CAS  Google Scholar 

  • Borisch B, Hennig I, Laeng RH, Waelti ER, Kraft R, Laissue J (1993) Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin lymphoma of the midline granuloma type. Blood 82:858

    PubMed  CAS  Google Scholar 

  • Bornkamm GW, Hudewentz J, Freese UK, Zimber U (1982) Deletion of the non-transforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region. J Virol 43:952

    PubMed  CAS  Google Scholar 

  • Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA (1991) Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphomas. Blood 78:3004

    PubMed  CAS  Google Scholar 

  • Boyle MJ, Vasak ET, Schuchnigg M, Turner JJ, Sculley T, Penny R, Cooper DA, Tindall B, Sewell WA (1993) Subtypes of Epstein-Barr virus (EBV) in Hodgkin’s disease: association between B-type EBV and immunocompromise. Blood 81:468

    PubMed  CAS  Google Scholar 

  • Brooks L, Yao QY, Rickinson AB, Young LS (1992) Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66:2689

    PubMed  CAS  Google Scholar 

  • Cleary ML, Nalesnik MA, Shearer WT, Sklar J (1988) Clonal analysis of transplant-associated lymphoproliferations based on the structure of genomic termini of the Epstein-Barr virus. Blood 72:349

    PubMed  CAS  Google Scholar 

  • Dambaugh T, Hennessy K, Chamnankit L, Kieff E (1984) U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81:7632

    Article  PubMed  CAS  Google Scholar 

  • de Bruin PC, Jiwa NM, van der Valk P, van Heerde P, Gordijn R, Ossenkoppele GJ, Walboomers JMM, Meijer CJLM (1993) Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-celi lymphomas: relation between latent membrane protein-1 positivity and clinical course. Histopathol 23:509

    Article  Google Scholar 

  • Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS (1993) Epstein-Barr virus and Hodgkin’s disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 177:339

    Article  PubMed  CAS  Google Scholar 

  • Delabie J, Ceuppens JL, Vandenberghe P, de Boer M, Coorevits L, de Wolf-Peters C (1993) The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin’s disease and contributes to the stimulating capacity of Hodgkin’s disease-derived cell lines. Blood 82:2845

    PubMed  CAS  Google Scholar 

  • Gerber P, Nonoyama M, Lucas S, Perlin E, Goldstein LI (1972) Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet ii:988

    Article  Google Scholar 

  • Glaser R, Zhang HY, Yao K, Zhu HC, Wang FX, Li GY, Wen DS, Li YP (1989) Two epithelial tumour cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 86:9524

    Article  PubMed  CAS  Google Scholar 

  • Gratama JW, Oosterveer MAP, Zwaan FE, Lepoutre J, Klein G, Ernberg I (1988) Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for the site of viral latency. Proc Natl Acad Sci USA 85:8693

    Article  PubMed  CAS  Google Scholar 

  • Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V, Freese UK (1985) Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia an AIDS-associated lesion. N Engl J Med 313:1564

    Article  PubMed  CAS  Google Scholar 

  • Gregory CD, Murray RJ, Edwards CF, Rickinson AB (1988) Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt’s lymphoma underlies tumour cell escape from virus-specific T cell surveillance. J Exp Med 167:1811

    Article  PubMed  CAS  Google Scholar 

  • Gregory CD, Rowe M, Rickinson AB (1990) Different Epstein-Barr virus (EBV)-B cell interactions in phenotypically distinct clones of a Burkitt lymphoma cell line. J gen Virol 71:1481

    Article  PubMed  CAS  Google Scholar 

  • Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, Oksenhendler E, Marelle L Pallesen G (1993 a) In situ demonstration of Epstein-Barr virus small RNAs (EBER1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumour morphology and primary site. Blood 82:619

    PubMed  CAS  Google Scholar 

  • Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ, Pallesen G (1993b) Epstein-Barr virus-latent gene expression and tumour cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 143:1072

    PubMed  CAS  Google Scholar 

  • Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T (1990) Epstein-Barr virus in nasal T-cell lymphomas in patients with midline granuloma. Lancet 335:128

    Article  PubMed  CAS  Google Scholar 

  • Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Müller-Lantzsch N, Stein H (1991a) Epstein-Barr virus latent membrane protein expression in Hodgkin-and Reed-Sternberg cells. Proc Natl Acad Sci USA 88:4766

    Article  PubMed  CAS  Google Scholar 

  • Herbst H, Dallenbach F, Hummel M, Niedobitek G, Finn T, Young LS, Rowe M, Müller-Lantzsch N, Stein H (1991b) Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. Blood 78:2666

    PubMed  CAS  Google Scholar 

  • Herbst H, Steinbrecher E, Niedobitek G, Young LS, Brooks L, Müller-Lantzsch N, Stein H (1992) Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin’s disease. Blood 80:484

    PubMed  CAS  Google Scholar 

  • Herbst H, Stein H, Niedobitek G (1993) Epstein-Barr virus and CD30+ malignant lymphomas. Crit Rev Oncog 4:191

    PubMed  CAS  Google Scholar 

  • Herndier BG, Sanchez HC, Chang KL, Chen YY, Weiss LM (1993) High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin’s disease. Am J Pathol 142:1073

    PubMed  CAS  Google Scholar 

  • Hummel H, Anagnostopoulos I, Korbjuhn P, Dallenbach F, Stein H (1993) Epstein-Barr virus infection patterns in malignant lymphomas. In The Epstein-Barr virus and associated diseases. Tursz T, Pagano JS, Ablashi DV, de The G, Lenoir G, Pearson GR, eds (Colloque INSERM/John Libbey Eurotext) 225:433

    Google Scholar 

  • Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J (1988) T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318:733

    Article  PubMed  CAS  Google Scholar 

  • Kamel OW, van de Rijn M, Weiss LM, Del Zoppo GJ, Hench PK, Robbins BA, Montgomery PG, Warnke RA, Dorfman RF (1993) Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328:1317

    Article  PubMed  CAS  Google Scholar 

  • Kanavaros P, Jiwa M, van der Valk P, Walboomers J, Horstman A, Meijer CJLM (1993) Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin’s disease and non-Hodgkin’s lymphomas arising in patients without overt pre-existing immunodeficiency. Hum Pathol 24:725

    Article  PubMed  CAS  Google Scholar 

  • Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, Hanada R, Kinoshita A, Sakurai M, Kobayashi N, Mizutani S (1993) Subclinical proliferation of Epstein-Barr virus infected T-lymphocytes in Epstein-Barr virus associated hemophagocytic syndrome (EBV-AHS). J Clin Invest 92:1444

    Article  PubMed  CAS  Google Scholar 

  • Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes SM, Gallimore PH, Rickinson AB (1992) Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virology 187:189

    Article  PubMed  CAS  Google Scholar 

  • Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ (1992) Localisation of Epstein-Barr virus cytotoxic T-cell epitopes using recombinant vaccinia — implications for vaccine development. J Exp Med 176:169

    Article  PubMed  CAS  Google Scholar 

  • Kieff E, Liebowitz D (1990) Epstein-Barr virus and its replication. In Virology. Fields BN, Knipe DM, eds (New York: Raven Press) p1889

    Google Scholar 

  • Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, Koizumi S, Osato T, Kobayashi I, Hamada I, Hirai K (1988) Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333:455

    Article  PubMed  CAS  Google Scholar 

  • Korbjuhn P, Anagnostopoulos I, Hummel M, Tiemann M, Dallenbach F, Parwaresch MR, Stein H (1993) Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood 82:217

    PubMed  CAS  Google Scholar 

  • Laux G, Economou A, Farrell P (1989) The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bi-directional latent promoter region. J gen Virol 70:3079

    Article  PubMed  CAS  Google Scholar 

  • Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB (1993) HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol 67:7428

    PubMed  CAS  Google Scholar 

  • Lewin N, Aman P, Mellstedt H, Zech L, Klein G (1988) Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines. Int J Cancer 41:892

    Article  PubMed  CAS  Google Scholar 

  • Locker J, Nalesnik M (1989) Molecular genetic analysis of lymphoid tumours arising after organ transplantation. Am J Pathol 135:977

    PubMed  CAS  Google Scholar 

  • Magrath I, Jain V, Bhatia K (1993) Molecular epidemiology of Burkitt’s lymphoma. In The Epstein-Barr virus and associated diseases. Tursz T, Pagano JS, Ablashi DV, de The G, Lenoir G, Pearson GR, eds (Colloque INSERM/John Libbey Eurotext) 225:377

    Google Scholar 

  • Miller G (1990) Epstein-Barr virus — Biology pathogenesis and medical aspects. In Virology. Fields BN, Knipe DM, eds (New York: Raven Press) p1921

    Google Scholar 

  • Mori M, Kurozumi H, Akagi K, Tanaka Y, Imai S, Osato T (1992) Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal infectious mononucleosis. N Engl J Med 327:58

    PubMed  CAS  Google Scholar 

  • Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk F, Vogelman J, (1989) Hodgkin’s disease and Epstein-Barr virus — Altered antibody pattern before diagnosis. N Engl J Med 320:689

    Article  PubMed  CAS  Google Scholar 

  • Munoz N, Davidson RJL, Witthoff B, Ericsson JE, De-The G (1978) Infectious mononucleosis and Hodgkin’s disease. Int J Cancer 22:10

    Article  PubMed  CAS  Google Scholar 

  • Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E, Rickinson AB (1990) Human cytotoxic T cell responses against Epstein-Barr virus nuclear antigens demonstrated using recombinant vaccinia viruses. Proc Natl Acad Sci USA 87:2906

    Article  PubMed  CAS  Google Scholar 

  • Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB (1992) Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV) — implications for the immune control of EBV-positive malignancies. J Exp Med 176:157

    Article  PubMed  CAS  Google Scholar 

  • Niedobitek G, Hamilton-Dutoit S, Herbst H, Finn T, Vetner M, Pallesen G, Stein H (1989) Identification of Epstein-Barr virus infected cells in tonsils of acute infectious mononucleosis by in situ hybridisation. Hum Pathol 20:796

    Article  PubMed  CAS  Google Scholar 

  • Niedobitek G, Young LS, Lau R, Brooks L, Greenspan D, Greenspan J, Rickinson AB (1991a) Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. J gen Virol 72:3035

    Article  PubMed  Google Scholar 

  • Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I, Friedrich R, Lobeck H, Sam CK, Araujo I, Rickinson AB, Stein H (1991b) Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 165:17

    Article  PubMed  CAS  Google Scholar 

  • Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crocker J, Rickinson AB, Stein H (1992a) Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 79:2520

    PubMed  CAS  Google Scholar 

  • Niedobitek G, Fahraeus R, Herbst H, Latza U, Ferszt A, Klein G, Stein H (1992b) The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells. Virchows Arch B 62:55

    Article  PubMed  CAS  Google Scholar 

  • Niedobitek G, Young LS (1994) Persistence of Epstein-Barr virus and the pathogenesis of virus-associated tumours. Lancet 343:333

    Article  PubMed  CAS  Google Scholar 

  • Nilsson K, Klein G, Henle W, Henle G (1971) The establishment of lymphoblastoid cell lines from adult and from foetal human lymphoid tissue and its dependence on EBV. Int J Cancer 8:443

    PubMed  CAS  Google Scholar 

  • Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin’s disease. Lancet 337:320

    Article  PubMed  CAS  Google Scholar 

  • Pallesen G, Hamilton-Dutoit SJ, Zhou X (1994) The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin’s disease: two new developments in the EBV field. Adv Cancer Res 62:179

    Article  Google Scholar 

  • Papadopoulos EB, Ladanyi M, Emanuel D, MacKinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, Young JW, Kernan NA, O’Reilly RJ (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330:1185

    Article  PubMed  CAS  Google Scholar 

  • Pedersen C, Gerstoft J, Lundgren JD, Skinhoj P, Bottzauw J, Geisler C, Hamilton-Dutoit SJ, Thorsen S, Lisse I, Ralfkiaer E, Pallesen G (1991) HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic factors. Eur J Cancer 27:1416

    Article  PubMed  CAS  Google Scholar 

  • Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883

    Article  PubMed  CAS  Google Scholar 

  • Rabson M, Gradoville L, Heston L, Miller G (1982) Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent. J Virol 44:834

    PubMed  CAS  Google Scholar 

  • Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J (1989) The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 92:177

    PubMed  CAS  Google Scholar 

  • Rickinson AB, Rowe M, Hart IJ, Yao QY, Henderson LE, Rabin H, Epstein MA (1984) T-cell-mediated regression of “spontaneous” and of Epstein-Barr virus-induced B cell transformation in vitro: studies with cyclosporin A. Cell Immunol 87:646

    Article  PubMed  CAS  Google Scholar 

  • Rickinson AB, Young LS, Rowe M (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 61:1310

    PubMed  CAS  Google Scholar 

  • Rowe M, Rooney CM, Rickinson AB, Lenoir GM, Rupani H, Moss DJ, Stein H, Epstein MA (1985) Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt’s lymphoma. Int J Cancer 35:435

    Article  PubMed  CAS  Google Scholar 

  • Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt’s lymphoma cells. EMBO J 6:2743

    PubMed  CAS  Google Scholar 

  • Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB (1989) Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J Virol 63:1031

    PubMed  CAS  Google Scholar 

  • Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB (1992) Three pathways of Epstein-Barr virus gene activation from EBNA 1-positive latency in B lymphocytes. J Virol 66:122

    PubMed  CAS  Google Scholar 

  • Rowlands DC, Ito M, Mangham DC, Reynolds G, Herbst H, Hallissey MT, Fielding JWL, Newbold KM, Jones EL, Young LS, Niedobitek G (1993) Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas. Br J Cancer 68:1014

    Article  PubMed  CAS  Google Scholar 

  • Sam CK, Brooks LA, Niedobitek G, Young LS, Prasad U, Rickinson AB (1993) Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a high nasopharyngeal carcinoma risk group. Int J Cancer 53:957

    Article  PubMed  CAS  Google Scholar 

  • Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E (1990) Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B and EBNA-3C genes. J Virol 64:4084

    PubMed  CAS  Google Scholar 

  • Sample J, Brooks L, Sample C, Young LS, Rowe M, Rickinson A, Kieff E (1991) Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is reflected in a novel EBNA-1 mRNA and transcriptional initiation site. Proc Natl Acad Sci USA 88:6343

    Article  PubMed  CAS  Google Scholar 

  • Shibata D, Weiss LM (1992) Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140:769

    PubMed  CAS  Google Scholar 

  • Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM (1993) Epstein-Barr virus-associated non-Hodgkin’s lymphoma in patients infected with the human immunodeficiency virus. Blood 81:2102

    PubMed  CAS  Google Scholar 

  • Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr virus replication in oropharyngeal cells. N Engl J Med 310:1225

    Article  PubMed  CAS  Google Scholar 

  • Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L (1989) Detection of a second widespread strain of Epstein-Barr virus. Lancet ii:761

    Article  Google Scholar 

  • Speck SH, Strominger JL (1989) Transcription of Epstein-Barr virus in latently infected, growth-transformed lymphocytes. Adv Viral Oncol 8:133

    Google Scholar 

  • Strauch B, Andrews LL, Siegel N, Miller G (1974) Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients with immunosuppressive drugs. Lancet i:234234

    Article  Google Scholar 

  • Swerdlow SH (1992) Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathol 20:373

    Article  CAS  Google Scholar 

  • Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH (1990) Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49:944

    Article  PubMed  CAS  Google Scholar 

  • Thomas JA, Felix DH, Wray D, Southam JC, Cubie H, Crawford DH (1991) Epstein Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. Am J Pathol 139:1369

    PubMed  CAS  Google Scholar 

  • Torsteinsdottir S, Brautbar C, Ben Bassat H, Klein E, Klein G (1988) Differential expression of HLA antigens on human B-cell lines of normal and malignant origin: a consequence of immune surveillance or a phenotype vestige of the progenitor cells? Int J Cancer 41:913

    Article  PubMed  CAS  Google Scholar 

  • Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831

    Article  PubMed  CAS  Google Scholar 

  • Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoti T, Kieff E (1987) Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci USA 84:3452

    Article  PubMed  CAS  Google Scholar 

  • Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E (1990) Epstein-Barr virus latent membrane protein (LMP-1) and nuclear proteins 2 and 3 c are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP-1 cooperatively induce CD23. J Virol 64:2309

    PubMed  CAS  Google Scholar 

  • Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ (1992) Detection and localisation of Epstein-Barr viral genome in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 79:1789

    PubMed  CAS  Google Scholar 

  • Wilson JB, Levine AJ (1992) The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice. Curr Top Microbiol Immunol 182:375

    PubMed  CAS  Google Scholar 

  • Wu TC, Mann RB, Charache P, Hayward SD, Staal S, Lambe BC, Ambinder RF (1990) Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin’s disease. Int J Cancer 46:801

    Article  PubMed  CAS  Google Scholar 

  • Yao QY, Rickinson AB, Epstein MA (1985) A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer 35:35

    Article  PubMed  CAS  Google Scholar 

  • Yao QY, Ogan P, Rowe M, Wood M, Rickinson AB (1989a) The Epstein-Barr virus:host balance in acute infectious mononucleosis patients receiving Acyclovir anti-viral therapy. Int J Cancer 43:61

    Article  PubMed  CAS  Google Scholar 

  • Yao QY, Ogan P, Rowe M, Wood M, Rickinson AB (1989b) Epstein-Barr virus-infected B cells persist in the circulation of Acyclovir-treated virus carriers. Int J Cancer 43:67

    Article  PubMed  CAS  Google Scholar 

  • Yao QY, Rowe M, Martin B, Young LS, Rickinson AB (1991) The Epstein-Barr virus carrier state: Dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J gen Virol 72:1579

    Article  PubMed  CAS  Google Scholar 

  • Yeung WM, Zong YS, Chiu CT, Sham JST, Choy DTK, Ng MH (1993) Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 53:746

    Article  PubMed  CAS  Google Scholar 

  • Yoneda N, Tatsumi E, Kawanishi M, Teshigawara K, Masuda S, Yamamura Y, Inui A, Yoshino G, Oimomi M, Baba S, Yamaguchi N (1990) Detection of Epstein-Barr virus genome in benign polyclonal proliferative T cells of a young male patient. Blood 76:172

    PubMed  CAS  Google Scholar 

  • Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB (1987) New type B isolates of Epstein-Barr virus from Burkitt’s lymphoma and from normal individuals in endemic areas. J gen Virol 68:2853

    Article  PubMed  CAS  Google Scholar 

  • Young L, Alfieri C, Hennessy K, Evans H, O’Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080

    Article  PubMed  CAS  Google Scholar 

  • Young L, Lau R, Rowe M, Niedobitek G, Packham G, Shanahan F, Rowe DT, Greenspan D, Greenspan JS, Rickinson AB, Farrell PJ (1991) Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol 65:2868

    PubMed  CAS  Google Scholar 

  • Zimber U, Adldinger HK, Lenoir GM, Vuillaume M, Knebel-Doeberitz M, Laux G, Desgranges C, Wittmann P, Freese UK, Schneider U, Bornkamm GW (1986) Geographical prevalence of two types of Epstein-Barr virus. Virology 154:56

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Cancer Studies, University of Birmingham, Birmingham, B15 2TT, UK

    Lawrence S. Young

  2. Department of Pathology, University of Birmingham, Birmingham, B15 2TT, UK

    Gerald Niedobitek

Authors
  1. Lawrence S. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerald Niedobitek
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Glasgow, Glasgow, Scotland

    Ruth F. Jarrett

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Plenum Press, New York

About this chapter

Cite this chapter

Young, L.S., Niedobitek, G. (1995). Epstein-Barr Virus and Lymphomas: An Overview. In: Jarrett, R.F. (eds) Etiology of Hodgkin’s Disease. NATO ASI Series, vol 280. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0339-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0339-8_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-8005-4

  • Online ISBN: 978-1-4613-0339-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation